| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:2791.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
From the Departments of Surgery (E.V.R., G.R.), Pathology (E.L.), and Cardiology (L.H.), University Hospital, and the Departments of Physiology (A.N.T., M.W.M.S., M.v.B., F.A.C.l.N.) and Biophysics (D.W.S.), Cardiovascular Research Institute, Maastricht, Netherlands.
Correspondence to F.A.C. le Noble, PhD, Department of Physiology, Maastricht University, PO Box 616, 6200 MD Maastricht, the Netherlands. E-mail flenoble{at}hotmail.com
| Abstract |
|---|
|
|
|---|
Methods and Results Chick embryos were incubated under normoxic (21% O2) or hypoxic (15% O2) conditions and evaluated at incubation day 19 by use of histological techniques, isolated heart preparations, and in vivo measurements of sympathetic arterial tone and systemic hemodynamics. Chronic hypoxia caused a 33% increase in mortality and an 11% reduction in body weight in surviving embryos. The lumen of the ascending aorta in hypoxic embryos was 23% smaller. Left ventricular systolic pressure was 22% lower, and heart weight/body weight ratio was 14% higher. In resistance arteries of hypoxic embryos, in vivo baseline tone was 23% higher, norepinephrine sensitivity was similar, and norepinephrine release from sympathetic nerves increased 2-fold, indicating sympathetic hyperinnervation. Mean arterial pressure and heart rate were similar under resting conditions, but chronically hypoxic embryos failed to maintain blood pressure during acute stress.
Conclusions This study indicates that mild hypoxia during embryonic development induces alterations in cardiac and vascular function and structure and affects hemodynamic regulation. These findings reveal that antenatal insults have profound effects on the control and design of the circulatory system that are already established at birth and may program for hypertension and heart failure at a later age.
Key Words: hypoxia hypertension nervous system, sympathetic heart defects, congenital
| Introduction |
|---|
|
|
|---|
Despite accumulating epidemiological evidence in support of this fetal programming concept, the physiological mechanism responsible for the association between low birth weight and cardiovascular disease is largely unknown. In addition, one of the critical questions that remains unanswered is whether the circulatory system is already affected at the time of birth. Uteroplacental insufficiency, resulting in chronic impairment in fetal oxygen and nutrient supply, is a major cause of intrauterine growth retardation. The objective of this study was to investigate whether chronic hypoxia during embryonic development (1) induces aberrant formation of the arterial tree, (2) affects cardiac function, and (3) alters functional control of the cardiovascular system. The study was performed in near-term chick embryos that were exposed to a physiologically relevant level of hypoxia of 15% throughout incubation. The chick embryo is an established experimental model in developmental biology. Because the avian embryo develops independently of its mother animal, this allows a unique comprehensive approach to study the effects of isolated hypoxia, consisting of histological techniques, isolated heart preparations, and in vivo measurements of arterial tone and systemic hemodynamics.
| Methods |
|---|
|
|
|---|
General Characteristics
To assess the effect of chronic hypoxia on general characteristics, we determined survival rate, body weight, and hematocrit. We also investigated whether chronic hypoxia prolonged the time to hatching.
Vascular Morphology
To determine the effect of chronic hypoxia on vascular morphology, embryos were killed, and the arterial tree was perfused at a standardized pressure of 30 mm Hg through a catheter introduced into the left ventricle (LV) with PBS and 1% phosphate-buffered paraformaldehyde (pH 7.4), both containing 0.1 mg/mL sodium nitroprusside.7 The ascending aorta was excised and fixed overnight in 1% phosphate-buffered paraformaldehyde. Segments were processed and embedded in paraffin, and 4-µm cross sections were stained with hematoxylin and eosin. Consecutive sections were stained with Lawsons solution (a modified elastica van Gieson staining) to visualize elastic laminae and immunolabeled with
-smooth muscle actin (monoclonal, 1:300, FITC-labeled; Sigma Chemical Co) as a smooth muscle cell marker. Immunostaining was performed according to conventional methods with anti-FITChrplabeled secondary antibodies (1:300, Roche Diagnostics Co) and 3,3'-diaminobenzidine as a chromogen. Sections were counterstained with hematoxylin and mounted with coverslips. The internal circumference (the length of the endothelium) and external circumference (the length of the external elastic lamina) were determined with a microscope coupled to a computerized morphometry system (Quantimet 570, Leica). The lumen diameter, outer vessel diameter, and wall/lumen ratio were calculated from the internal circumference and external circumference, respectively, assuming a circular configuration.
Cardiac Function and Geometry
The effect of chronic hypoxia on LV performance was evaluated with a retrograde Langendorff isolated heart perfusion system originally designed for the murine heart.8 In short, after the death of the embryo, the heart was excised and placed in ice-chilled perfusion buffer. A cannula was inserted into the aortic outflow tract, the heart was placed in the temperature-controlled (37°C) perfusion setup, and retrograde perfusion with a modified Krebs-Henseleit solution was started. Aortic pressure was measured through a side branch of the aortic cannula and was kept at 30 mm Hg, which was similar to the mean arterial pressure at this stage of development. The hearts were paced at a physiological rate of 225 bpm via platinum electrodes attached to the right atrium. LV pressure was measured via a PE-50 catheter inserted into the LV cavity at the apex and connected to a standard pressure transducer (Baxter Uniflow, Baxter BV). After an equilibration period of 15 minutes, LV end-diastolic pressure, LV systolic pressure, and aortic pressure were recorded by a data acquisition system. The maxima and minima of the first derivative of LV pressure (LV dP/dtmax and LV dP/dtmin) were calculated.
The effect of chronic hypoxia on cardiac mass was determined on freshly excised hearts. For cardiac histology, hearts were fixed in diastole, excised, placed overnight into 1% phosphate-buffered paraformaldehyde, processed routinely, and embedded in paraffin. Sections 4 µm thick were cut perpendicular to the long axis of the heart and stained with hematoxylin and eosin. LV free wall thickness and cross-sectional area and ventricular septum thickness were determined with a microscope coupled to a computerized morphometry system (Quantimet 570, Leica).
Peripheral Arterial Control
The effect of chronic hypoxia on control of peripheral arterial tone was assessed in vivo by measurement of diameter changes of mesenteric resistance arteries in response to pharmacological and physiological stimuli by means of intravital videomicroscopy, as described in detail elsewhere.9 In short, the egg was opened, the chorioallantoic membrane was penetrated, and a segment of the intestine with its mesentery was exposed and stabilized. The egg was placed in a temperature- and air flowcontrolled single-egg chamber (37°C, 4 L/min). Experiments were performed at an O2 level of 21% unless stated otherwise. Second-order mesenteric resistance arteries were visualized with an intravital microscope setup equipped with a 20x long-working-distance objective (optical magnification 880x, final resolution 1 µm). Images were recorded on videotape, and arterial diameters were analyzed offline with an image-shearing device (model 908, IPM). Changes in diameter are presented as percentage of baseline diameter.
-Adrenergic arterial tone under baseline conditions was determined by measurement of the dilator response to the topically applied
-adrenoceptor antagonist phentolamine (20-µL aliquots, 10-3 mol/L).
-Adrenoceptormediated vasoconstrictor capacity was assessed by measurement of changes in arterial diameter in response to sequential application of increasing concentrations of norepinephrine (20-µL aliquots, 10-6 to 10-2 mol/L). Maximal diameters were determined by measurement of the vasodilator response to acetylcholine (20-µL aliquots, 10-2 mol/L). Administration of these drug concentrations to the mesentery has previously been shown to result in physiologically relevant vasomotor responses.9
Functional autonomic nervous control of the peripheral vasculature was assessed by measurement of the arterial constrictor response to topically applied tyramine (20-µL aliquots, 10-6 to 10-2 mol/L). Tyramine releases norepinephrine from perivascular sympathetic nerve endings without affecting presynaptic reuptake. Because the contractile response to tyramine reflects the total norepinephrine content of the perivascular sympathetic nerve endings,10 this is a sophisticated method for assessing sympathetic nerve function in vivo.
Phentolamine, norepinephrine, acetylcholine, and tyramine were obtained from Sigma Chemical Co. Drugs were dissolved in HEPES-buffered Krebs solution with the following composition (in mmol/L): NaCl 143.3, KCl 4.7, MgSO4 1.2, KH2PO4 1.2, CaCl2 2.5, glucose 5.6, and HEPES 15; pH 7.4. Drugs were freshly prepared on the day of the experiment; the temperature of the solutions at the time of administration was 37°C.
Systemic Hemodynamics
To investigate the influence of chronic hypoxia on central hemodynamic control, we measured mean arterial pressure and heart rate according to a previously described method.9 In short, a catheter was inserted into a branch of the chorioallantoic artery and connected to a pressure transducer (Baxter Uniflow, Baxter BV), which was placed at egg height. Pressure signals were recorded on a computer by use of a data acquisition system, and the heart rate was calculated. In addition to measurements under baseline conditions (at 21% O2), blood pressure, heart rate, and peripheral arterial tone were also measured during acute severe hypoxic stress. An acute reduction in blood oxygen level is a standard stimulus for triggering a stress response in the embryo, which is characterized by bradycardia and enhanced autonomic nervous system output aimed at maintaining blood pressure. Acute hypoxia was induced by replacing the ambient air in the egg chamber by 100% N2 (4 L/min) for 5 minutes.
Data Analysis
Data are expressed as mean±SEM. The term n refers to the number of embryos. All experiments were performed in separate series of embryos. Statistical comparisons between groups were made with the Mann-Whitney U test. Statistical comparisons within groups were made with the Wilcoxon signed-rank test. Statistical significance was defined as P<0.05.
| Results |
|---|
|
|
|---|
Vascular Morphology
The effect of chronic hypoxia on vascular morphology is shown in Figure 1. The luminal diameter of the ascending aorta was smaller in the CH (n=11) than the N (n=7) group (328±28 versus 430±28 µm, P<0.05; Figure 2A), whereas the outer vessel diameters were not different between the 2 groups (896±40 versus 890±68 µm). As a result, the wall/lumen ratio was higher in the CH than the N group (2.0±0.32 versus 1.1±0.17, P<0.05; Figure 2B). These data indicate that hypoxia is associated with reduced lumen size of the ascending aorta in the presence of hypertrophic growth.
|
|
Cardiac Function and Geometry
LV function was determined under similar conditions (aortic pressure 30 mm Hg, heart rate 225 bpm) in the CH and N groups (both n=5). These values resembled the in vivo measured mean arterial pressure and heart rate at this stage of development (see below). There was no significant difference in end-diastolic pressure between the 2 groups (8±2.4 versus 8±2.3 mm Hg). LV systolic pressure was 22% lower in the CH than the N group (35±1.0 versus 45±3.5 mm Hg, P<0.05; Figure 3). LV dP/dtmax and LV dP/dtmin were also lower in the CH group (836±104 versus 1109±101 mm Hg/s, P=0.076, and 679±29 versus 957±68 mm Hg/s, P<0.01).
|
The heart weight/body weight ratio, as a first-order index of cardiac hypertrophy, was higher (7.5±0.18x10-3 versus 6.6±0.10x10-3, P<0.05) in the CH (n=14) than the N (n=8) group. LV free wall thickness and area were comparable between the 2 groups (0.73±0.06 versus 0.73±0.07 mm and 2.28±0.28 versus 2.23±0.21 mm2, respectively), whereas septum thickness was reduced in the CH embryos (0.77±0.02 versus 1.18±0.07 mm2, P<0.001). These data indicate that hypoxia is associated with disturbed cardiac contractile function in the presence of mild hypertrophy.
Peripheral Arterial Control
Absolute arterial diameters under baseline conditions were smaller in the CH group than the N group (74±4.0 versus 91±3.4 µm).
-Adrenoceptor blockade with phentolamine induced a significantly stronger dilation of the mesenteric resistance arteries in the CH (n=5) group than the N (n=7) group (to 134±3.4% versus 111±2.4% of baseline, P<0.01; Figure 4), indicating a 23% higher baseline arterial tone in the CH group. Application of increasing concentrations of norepinephrine caused a decrease in arterial diameter in the CH (n=8) and N (n=9) groups. Maximal constrictor response at 10-3 mol/L norepinephrine was similar in the 2 groups (to 34±3.6% and 29±2.0% of baseline; Figure 5). Absolute maximal diameters in response to 10-2 mol/L acetylcholine were similar in the 2 groups (104±5.0 and 104±4.9 µm).
|
|
Application of increasing concentrations of tyramine induced a gradual reduction in mesenteric arterial diameter in both the CH and N groups (both n=8, data not shown). Maximal arterial constriction was always obtained at 10-3 mol/L tyramine and was greater in the CH than the N group (37±3.6% versus 19±5.2% decrease of baseline, P<0.01; Figure 6). These data indicate that peripheral arterial tone was enhanced in CH embryos because of increased functional sympathetic innervation in the presence of similar
-adrenergic sensitivity of the peripheral vasculature.
|
Systemic Hemodynamics
Under baseline conditions, mean arterial pressure and heart rate were similar in the CH (27±2.2 mm Hg and 205±6 bpm, n=8) and N (25±1.4 mm Hg and 199±9 bpm, n=9) groups. During acute hypoxic stress, however, mean arterial pressure decreased significantly in the CH group (to 22±1.8 mm Hg, P<0.05; Figure 7A), whereas it was maintained in the N group (27±1.0 mm Hg). Acute hypoxia was associated with a significant (P<0.01) degree of bradycardia (132±3 and 117±6 bpm) and an equally significant (P<0.01) constriction of the mesenteric resistance arteries in the CH (n=9) and N (n=10) groups (to 42±2.5% and 46±5.3% of baseline; Figure 7B). These data indicate that chronic hypoxia is accompanied by failure to maintain blood pressure during stress.
|
| Discussion |
|---|
|
|
|---|
We observed that as a consequence of medial hypertrophy, the lumen size of the ascending aorta was smaller in chronically hypoxic embryos. These changes in structural characteristics of the aortic wall are associated with an increase in resistance and a decrease in elastic properties, leading to reduced compliance. Similar alterations are implied in the pathogenesis of essential hypertension.11
Our in vivo measurements in the mesenteric vascular bed revealed an increase in arterial tone under baseline conditions. Furthermore, the contractile responsiveness to direct stimulation of perivascular sympathetic nerves by tyramine was 2-fold higher in chronically hypoxic embryos, whereas maximal responsiveness and sensitivity to norepinephrine were not altered. Together, these data indicate that chronic hypoxia induces sympathetic hyperinnervation of resistance arteries, leading to an increase in adrenergic arterial tone compatible with changes observed in adult hypertension.
Both reduced arterial lumen size and increased arterial tone play a fundamental role in the origin of essential hypertension. Therefore, our study shows, for the first time, that chronic embryonic hypoxia may establish the structural and functional basis for hypertension.
We found a 22% reduction in LV systolic pressure and lower positive and negative dP/dt in chronically hypoxic embryos, pointing to significantly diminished cardiac contractile function after chronic hypoxia. The heart weight/body weight ratio was 14% higher in hypoxic embryos, which is suggestive of a mild hypertrophic response. Together, these data indicate that chronic hypoxia induces alterations in function and mass of the embryonic heart compatible with moderate cardiac failure.
To extend this idea, we evaluated the regulation of systemic hemodynamics during acute severe hypoxic stress. This is a well-known stimulus for triggering a chemoreflex, which in the near-term embryo is normally characterized by bradycardia, elevated peripheral vascular resistance, and maintenance of blood pressure. This response is essential to maintain perfusion of the vital organs during an episode of acute hypoxia.12 Interestingly, we observed that arterial pressure dropped significantly in chronically hypoxic embryos during acute hypoxic stress, in contrast to the expected constant blood pressure in their normoxic counterparts. Because the degree of bradycardia and level of constriction in peripheral resistance arteries were similar in the 2 groups, it is highly likely that the decline in cardiac function in chronically hypoxic embryos accounts for this effect. These data provide the first evidence that hypoxia-associated alterations in the cardiovascular system lead to hemodynamic collapse under stress conditions in the near-term embryo.
Both molecular and hemodynamic mechanisms may account for the morphological and functional defects in the heart and vasculature of chronically hypoxic embryos. Endothelin-1, which, like vascular endothelial growth factor (VEGF), is a downstream target molecule of the hypoxia-sensitive transcription factor hypoxia-inducible factor (HIF)-1
, 13 is a trophic factor for vascular smooth muscle cells and influences the development of neural crestderived organs like the aortic outflow tract and the enteric nervous system.14 Because we find alterations at similar levels of the cardiovascular system, endothelin-1 may be a potential mediator and an interesting subject for future pharmacological interventions. We also observed a 2-fold increase in the constrictor response to tyramine after hypoxia, implying enhanced norepinephrine release from perivascular sympathetic nerves. This may be explained by hypoxia/HIF-2
driven enhanced activity of the enzyme tyrosine hydroxylase, the rate-limiting enzyme in norepinephrine synthesis in sympathetic nerves.15,16 Finally, in line with our observations, mice with mild overexpression of VEGF-A show severe fetal cardiac and vascular abnormalities and die at midgestation.17 Genetic deletion of the HIF-1 response element or the VEGF coreceptor neuropilin-1 affects neuronal projection, implying a role for hypoxic signaling in neural regulation.18,19 Thus, on the basis of the fundamental role of these factors in the embryonic design of the circulatory system, we postulate that hypoxia may alter the orchestration of the expression of these factors during a critical period of embryonic development.
In addition, observed changes, such as enhanced sympathetic tone in the resistance vasculature, may reflect secondary hemodynamic adaptations. It is well known that patients with heart failure trigger similar compensatory neuroendocrine mechanisms aimed at restoring systemic arterial pressure. It may therefore be postulated that the decreased aortic lumen size imposes an increased workload on the heart, resulting in cardiac hypertrophy with subsequent LV dysfunction, which enhances sympathetic nervous activity.
By using an integrative physiological approach, the present study clearly showed that exposure of the embryo to mild hypoxia leads to abnormalities in cardiovascular function that may be related to the origin of hypertension. Our future investigations will address whether the changes observed in the chick embryo persist postnatally. Additional clinical research is needed to identify whether our postulates hold in human low-birth-weight neonates, for example, by noninvasive imaging of the heart and ascending aorta and nailfold microvascular microscopy to establish in vivo regulation of vascular tone.
| Acknowledgments |
|---|
Received December 28, 2001; revision received March 20, 2002; accepted March 21, 2002.
| References |
|---|
|
|
|---|
2. Barker DJP, Osmond C, Simmonds SJ, et al. The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ. 1993; 306: 422426.
3.
Loos RJF, Fagard R, Beunen G, et al. Birth weight and blood pressure in young adults: a prospective twin study. Circulation. 2001; 104: 16331638.
4. Hales CN, Barker DJP, Clark PMS. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991; 303: 10191022.
5.
Leeson CPM, Whincup PH, Cook DG, et al. Flow-mediated dilation in 9- to 11-year-old children: the influence of intrauterine and childhood factors. Circulation. 1997; 96: 22332238.
6.
Leeson CPM, Kattenhorn M, Morley R, et al. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation. 2001; 103: 12641268.
7.
Lutgens E, Daemen M, Kockx M, et al. Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage. Circulation. 1999; 99: 276283.
8. De Windt LJ, Willems J, Reneman RS, et al. An improved isolated, left ventricular ejecting, murine heart model: functional and metabolic evaluation. Pflugers Arch. 1999; 437: 182190.[CrossRef][Medline] [Order article via Infotrieve]
9.
Rouwet EV, De Mey JGR, Slaaf DW, et al. Development of vasomotor responses in fetal mesenteric arteries. Am J Physiol. 2000; 279: H1097H1105.
10. Takauchi Y, Yamazaki T, Akiyama T. Tyramine-induced endogenous noradrenaline efflux from in situ cardiac sympathetic nerve endings in cats. Acta Physiol Scand. 2000; 168: 287293.[CrossRef][Medline] [Order article via Infotrieve]
11.
Van Gorp AW, Van Ingen Schenau DS, Hoeks APG, et al. In spontaneously hypertensive rats alterations in aortic wall properties precede development of hypertension. Am J Physiol. 2000; 278: H1241H1247.
12.
Inoue M, Fujishiro N, Imanaga I. Hypoxia and cyanide induce depolarization and catecholamine release in dispersed guinea-pig chromaffin cells. J Physiol. 1998; 507: 807818.
13. Semenza GL. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev. 1998; 8: 588594.[CrossRef][Medline] [Order article via Infotrieve]
14. Kempf H, Linares C, Corvol P, et al. Pharmacological inactivation of the endothelin type A receptor in the early chick embryo: a model of mispatterning of the branchial arch derivatives. Development. 1998; 125: 49314941.[Abstract]
15.
Tian H, Hammer RE, Matsumoto AM, et al. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 1998; 12: 33203324.
16. Favier J, Kempf H, Corvol P, et al. Cloning and expression pattern of EPAS1 in the chicken embryo. FEBS Lett. 1999; 462: 1924.[CrossRef][Medline] [Order article via Infotrieve]
17. Miquerol L, Langille BL, Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development. 2000; 127: 39413946.[Abstract]
18. Oosthuyse B, Moons L, Storkebaum E, et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promotor causes motor neuron degeneration. Nat Genet. 2001; 28: 131138.[CrossRef][Medline] [Order article via Infotrieve]
19. Chen H, He Z, Bagri A, et al. Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins. Neuron. 1998; 21: 12831290.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
J. Copeland and E. M. Dzialowski Effects of hypoxic and hyperoxic incubation on the reactivity of the chicken embryo (Gallus gallus) ductus arteriosi in response to catecholamines and oxygen Exp Physiol, January 1, 2009; 94(1): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, X. T. Wang, Y. Chamba, Y. Ling, and C. X. Wu Influences of Hypoxia on Hatching Performance in Chickens with Different Genetic Adaptation to High Altitude Poult. Sci., October 1, 2008; 87(10): 2112 - 2116. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaffer, T. Burkhardt, D. Muller-Vizentini, M. Rauh, M. Tomaske, R. A. Mieth, U. Bauersfeld, and E. Beinder Cardiac autonomic balance in small-for-gestational-age neonates Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H884 - H890. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. V. Jones, F. le Noble, and A. Eichmann What Determines Blood Vessel Structure? Genetic Prespecification vs. Hemodynamics. Physiology, December 1, 2006; 21(6): 388 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Segar, R. D. Roghair, E. M. Segar, M. C. Bailey, T. D. Scholz, and F. S. Lamb Early gestation dexamethasone alters baroreflex and vascular responses in newborn lambs before hypertension Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R481 - R488. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Labat, R. S. A. Cunha, P. Challande, M. E. Safar, and P. Lacolley Respective contribution of age, mean arterial pressure, and body weight on central arterial distensibility in SHR Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1534 - H1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Alexander Fetal programming of hypertension Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R1 - R10. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Safar and H. S. Boudier Vascular Development, Pulse Pressure, and the Mechanisms of Hypertension Hypertension, July 1, 2005; 46(1): 205 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Alexander, A. E. Hendon, G. Ferril, and T. M. Dwyer Renal Denervation Abolishes Hypertension in Low-Birth-Weight Offspring From Pregnant Rats With Reduced Uterine Perfusion Hypertension, April 1, 2005; 45(4): 754 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. le Noble, V. Fleury, A. Pries, P. Corvol, A. Eichmann, and R.S. Reneman Control of arterial branching morphogenesis in embryogenesis: go with the flow Cardiovasc Res, February 15, 2005; 65(3): 619 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Williams, M. E. Campbell, I. C. McMillen, and S. T. Davidge Differential effects of maternal hypoxia or nutrient restriction on carotid and femoral vascular function in neonatal rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R360 - R367. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang Prenatal Hypoxia and Cardiac Programming Reproductive Sciences, January 1, 2005; 12(1): 2 - 13. [Abstract] [PDF] |
||||
![]() |
D. A. Crossley II and J. Altimiras Cardiovascular development in embryos of the American alligator Alligator mississippiensis: effects of chronic and acute hypoxia J. Exp. Biol., January 1, 2005; 208(1): 31 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Villamor, C. G. A. Kessels, K. Ruijtenbeek, R. J. van Suylen, J. Belik, J. G. R. De Mey, and C. E. Blanco Chronic in ovo hypoxia decreases pulmonary arterial contractile reactivity and induces biventricular cardiac enlargement in the chicken embryo Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R642 - R651. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao and L. Zhang Calcium Homeostasis and Contraction of the Uterine Artery: Effect of Pregnancy and Chronic Hypoxia Biol Reprod, April 1, 2004; 70(4): 1171 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Broberg, G. D. Giraud, J. M. Schultz, K. L. Thornburg, A. R. Hohimer, and L. E. Davis Fetal anemia leads to augmented contractile response to hypoxic stress in adulthood Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R649 - R655. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |